Horizon Therapeutics plc Wins 2022 International CSR Excellence Award for #RAREis Adoption Fund
businesswire.com
news
2022-05-31 00:00:00

May 31, 2022 04:01 PM Eastern Daylight Time DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced the company has won an International Corporate Social Responsibility (CSR) Excellence Award for its partnership with Gift of Adoption to co-create the #RAREis Adoption Fund. As part of the award, Horizon will be formally recognized in the next CSR World Leaders report, which will be published in November 2022.

Horizon partners with Gift of Adoption to support children with rare diseases who are adopted from orphanages around the world so they can thrive with their new families.
